Rexford Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Sell
7,607
-610
-7% -$7.29K 0.06% 208
2026
Q1
$49.2K Hold
8,217
0.04% 236
2025
Q4
$58.9K Sell
8,217
-3,163
-28% -$25K 0.04% 234
2025
Q3
$122K Buy
11,380
+1,480
+15% +$14.5K 0.09% 208
2025
Q2
$95.8K Buy
+9,900
New +$102K 0.08% 218

Other funds holding OGN

Rexford Capital's OGN Position: Q2 2026 in Review

Rexford Capital reduced its Organon & Co (OGN) stake by 7.4% in Q2 2026, selling an estimated $7.29K and leaving 7,607 shares worth $103K. The position accounts for 0.06% of the portfolio, ranked #208.

Rexford Capital first reported a position in OGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $122K in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Rexford Capital held 7,607 shares of Organon & Co worth $103K as of Q2 2026.
  • Rexford Capital sold 610 Organon & Co shares in Q2 2026, an estimated $7.29K.
  • Organon & Co made up 0.06% of Rexford Capital's portfolio in Q2 2026, its #208 holding.
  • Rexford Capital first reported a position in Organon & Co in Q2 2025 and has held it in 5 quarters since.
  • Rexford Capital's Organon & Co position peaked at $122K in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.